Biotechnology Regulatory Authority of India

Last updated

The Biotechnology Regulatory Authority of India (BRAI) is a proposed regulatory body in India for uses of biotechnology products including genetically modified organisms (GMOs). [1] The institute was first suggested under the Biotechnology Regulatory Authority of India (BRAI) draft bill prepared by the Department of Biotechnology in 2008. [2] Since then, it has undergone several revisions. [3]

Contents

The bill has faced opposition from farmer groups and anti-GMO activists. [4] [5]

Overview

On 23 January 2003, India ratified the Cartagena Protocol which protects biodiversity from potential risks of genetically modified organisms, the products of modern biotechnology. The protocol requires setting up of a regulatory body. [6] Currently, the Genetic Engineering Approvals Committee, a body under the Ministry of Environment and Forests (India) is responsible for approval of genetically engineered products in India. If the bill is passed, the responsibility will be taken over by the Environment Appraisal Panel, a sub-division of the BRAI. [3]

According to the bill, BRAI will have a chairperson, two full-time members and two part-time members; all will be required to have expertise in life sciences and biotechnology in agriculture, health care, environment and general biology. The bill also proposes setting up an inter-ministerial governing body, to oversee the performance of BRAI, and a National Biotechnology Advisory Council of stakeholders to provide feedback on the use of biotechnology products and organisms in the society. [1] The regulatory body will be an autonomous and statutory agency to regulate the research, transport, import, and manufacture biotechnology products and organisms. [1]

Criticism

Suman Sahai, founder of the Gene Campaign, has called the bill flawed. According to her, the bill is proposing new institutes without clearly defining their powers and responsibilities. She has also stated that the bill was introduced without consulting the people who will be affected by the bill. [4]

P. M. Bhargava, founder of the Centre for Cellular and Molecular Biology, has also opposed the bill. He has called the bill unconstitutional, as agricultural policy is the domain of state governments. He pointed out that the bill proposes formation of several subdivisions and has argued that they will consist of bureaucrats with no scientific knowledge. He has accused the Department of Biotechnology, which will be involved in selection of members, as a promoter of genetic technology in India. He has pointed out that the broadly defined term "confidential commercial information" has been kept outside the purview of the Right to Information Act. He had stated that the bill uses vague wordings which would criminalize sequencing or isolation of DNA and PCR techniques, requiring approval for each usage. Thus, hindering research and education. He pointed out the bill has no provision for mandatory labelling of GM foods. He criticized giving the body power to punish parties making false or misleading statements about GM crops, calling it unprecedented. [7]

In September 2010, Jairam Ramesh, then Environment Minister, pointed out that the body is only deals with safety and efficacy of biotechnology products. The issue of commercialization has been left unaddressed. The decisions regarding commercialization can fall under the purview of Ministry of Environment and Forests, Ministry of Health, Ministry of Agriculture, or Department of Science and Technology. [3]

On the other hand, Association of Biotechnology Led Enterprises (ABLE) has supported the bill. J.S. Rehman, an entomologist and a former member of the Review Committee on Genetic Manipulation, has stated that most protesters associate genetic engineering with Monsanto, as a result development of Indian biotech is being hindered. [8]

See also

Related Research Articles

<span class="mw-page-title-main">Biotechnology</span> Use of living systems and organisms to develop or make useful products

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services.

<span class="mw-page-title-main">Genetic engineering</span> Manipulation of an organisms genome

Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The first recombinant DNA molecule was made by Paul Berg in 1972 by combining DNA from the monkey virus SV40 with the lambda virus. As well as inserting genes, the process can be used to remove, or "knock out", genes. The new DNA can be inserted randomly, or targeted to a specific part of the genome.

The Monsanto Company was an American agrochemical and agricultural biotechnology corporation founded in 1901 and headquartered in Creve Coeur, Missouri. Monsanto's best known product is Roundup, a glyphosate-based herbicide, developed in the 1970s. Later, the company became a major producer of genetically engineered crops. In 2018, the company ranked 199th on the Fortune 500 of the largest United States corporations by revenue.

<span class="mw-page-title-main">Genetically modified crops</span> Plants used in agriculture

Genetically modified crops are plants used in agriculture, the DNA of which has been modified using genetic engineering methods. Plant genomes can be engineered by physical methods or by use of Agrobacterium for the delivery of sequences hosted in T-DNA binary vectors. In most cases, the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, environmental conditions, reduction of spoilage, resistance to chemical treatments, or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.

Since the advent of genetic engineering in the 1970s, concerns have been raised about the dangers of the technology. Laws, regulations, and treaties were created in the years following to contain genetically modified organisms and prevent their escape. Nevertheless, there are several examples of failure to keep GM crops separate from conventional ones.

<span class="mw-page-title-main">Genetically modified food controversies</span> Controversies over GMO food

Genetically modified food controversies are disputes over the use of foods and other goods derived from genetically modified crops instead of conventional crops, and other uses of genetic engineering in food production. The disputes involve consumers, farmers, biotechnology companies, governmental regulators, non-governmental organizations, and scientists. The key areas of controversy related to genetically modified food are whether such food should be labeled, the role of government regulators, the objectivity of scientific research and publication, the effect of genetically modified crops on health and the environment, the effect on pesticide resistance, the impact of such crops for farmers, and the role of the crops in feeding the world population. In addition, products derived from GMO organisms play a role in the production of ethanol fuels and pharmaceuticals.

The United States is the largest grower of commercial crops that have been genetically engineered in the world, but not without domestic and international opposition.

Religious views on genetically modified foods have been mixed, although as yet, no genetically modified foods have been designated as unacceptable by religious authorities.

Genetically modified wheat is wheat that has been genetically engineered by the direct manipulation of its genome using biotechnology. As of 2020, no GM wheat is grown commercially, although many field tests have been conducted, with one wheat variety, Bioceres HB4 Wheat, obtaining regulatory approval from the Argentinean government.

<span class="mw-page-title-main">Genetically modified soybean</span> Soybean that has had DNA introduced into it using genetic engineering techniques

A genetically modified soybean is a soybean that has had DNA introduced into it using genetic engineering techniques. In 1996, the first genetically modified soybean was introduced to the U.S. by Monsanto. In 2014, 90.7 million hectares of GM soybeans were planted worldwide, this is almost 82% of the total soybeans cultivation area.

<span class="mw-page-title-main">Regulation of genetic engineering</span> Overview of the regulation of genetic engineering

The regulation of genetic engineering varies widely by country. Countries such as the United States, Canada, Lebanon and Egypt use substantial equivalence as the starting point when assessing safety, while many countries such as those in the European Union, Brazil and China authorize GMO cultivation on a case-by-case basis. Many countries allow the import of GM food with authorization, but either do not allow its cultivation or have provisions for cultivation, but no GM products are yet produced. Most countries that do not allow for GMO cultivation do permit research. Most (85%) of the world's GMO crops are grown in the Americas. One of the key issues concerning regulators is whether GM products should be labeled. Labeling of GMO products in the marketplace is required in 64 countries. Labeling can be mandatory up to a threshold GM content level or voluntary. A study investigating voluntary labeling in South Africa found that 31% of products labeled as GMO-free had a GM content above 1.0%. In Canada and the USA labeling of GM food is voluntary, while in Europe all food or feed which contains greater than 0.9% of approved GMOs must be labelled.

Genetic engineering in the European Union has varying degrees of regulation.

The Farmer Assurance Provision refers to Section 735 of US H.R. 933, a bill that was passed by the Senate on March 20, 2013, and then signed into law as part of the Consolidated and Further Continuing Appropriations Act, 2013 by President Barack Obama on March 26, 2013. The provisions of this law remained in effect for six months, until the end of the fiscal year on September 30, 2013. The Farmer Assurance Provision was discontinued in Sec. 101 of the Continuing Appropriations Act, 2014. The bill is commonly referred to as the "Monsanto Protection Act" by its critics.

<span class="mw-page-title-main">March Against Monsanto</span> International protest movement

The March Against Monsanto is an international grassroots movement and protest against Monsanto, a producer of genetically modified organisms (GMOs) and Roundup, a glyphosate-based herbicide. The movement was founded by Tami Canal in response to the failure of California Proposition 37, a ballot initiative which would have required labeling food products made from GMOs. Advocates support mandatory labeling laws for food made from GMOs.

GMO Answers is a front group launched by the agricultural biotechnology industry in July 2013 to participate in public debate around genetically modified organisms (GMOs) in crops in the U.S. food supply.

Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. The Indian biotechnology sector is fast growing, and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.

<span class="mw-page-title-main">GMO conspiracy theories</span> Conspiracy theories related to GMOs

GMO conspiracy theories are conspiracy theories related to the production and sale of genetically modified crops and genetically modified food. These conspiracy theories include claims that agribusinesses, especially Monsanto, have suppressed data showing that GMOs cause harm, deliberately cause food shortages to promote the use of GM food, or have co-opted government agencies such as the United States Food and Drug Administration or scientific societies such as the American Association for the Advancement of Science. Critics charge that GMO conspiracy theories are largely promulgated by those opposing the production and sale of GMOs, and instances of unsubstantiated conspiracy theories have lately occurred in the context of public health issues that are mostly unrelated to GMOs, including the 2015–16 Zika virus outbreak and concerns over food safety at Chipotle Mexican Grill.

India and China are the two largest producers of genetically modified products in Asia. India currently only grows GM cotton, while China produces GM varieties of cotton, poplar, petunia, tomato, papaya and sweet pepper. Cost of enforcement of regulations in India are generally higher, possibly due to the greater influence farmers and small seed firms have on policy makers, while the enforcement of regulations was more effective in China. Other Asian countries that grew GM crops in 2011 were Pakistan, the Philippines and Myanmar. GM crops were approved for commercialisation in Bangladesh in 2013 and in Vietnam and Indonesia in 2014.

Genetic engineering in North America is any genetic engineering activities in North America

This article discusses topics relating to genetic engineering within Oceania. Currently New Zealand and Australia require labeling so consumers can exercise choice between foods that have genetically modified, conventional, or organic origins.

References

  1. 1 2 3 "Regulatory Authority to be Set Up on Bio-Technology". Press Information Bureau, Government of India. 22 May 2012. Retrieved 24 March 2014.
  2. "Draft: National Biotechnology Regulatory Bill, 2008" (PDF).
  3. 1 2 3 "BRAI Bill leaves biotech commercialisation in limbo". The Hindu . 9 September 2010. Retrieved 24 March 2014.
  4. 1 2 "Activists oppose Biotechnology Regulatory Authority of India bill". DNA India . 9 July 2013. Retrieved 24 March 2014.
  5. Shaheen Contractor (23 August 2013). "No BRAI Bill, Please". Business Line . Retrieved 24 March 2014.
  6. "Cartagena Protocol on Biosafety (CPB)". Ministry of Environment and Forests (India). Archived from the original on 7 July 2014. Retrieved 24 March 2014.
  7. Pushpa M. Bhargava (5 January 2012). "Unconstitutional, unethical, unscientific". The Hindu . Retrieved 24 March 2014.
  8. Vasudevan Mukunth (2 September 2013). "Let's unMonsanto the debate" . Retrieved 1 April 2014.

Further reading